Hexagon Nutrition IPO sails through at 10.98x on Day 3, retail piles in at 11.71x
The clinical nutrition maker behind Pentasure and Pediagold closed its ₹138.87 cr OFS issue 10.98x subscribed, with NII at 24.80x and retail at 11.71x. Priced at ₹42-45 with GMP of ₹6.5, the 75-country exporter lists 12 June. SBICAP and BP Equities flag a subscribe call on 14% EBITDA margins and 0.18 D/E.
Hexagon Nutrition's ₹138.87 cr OFS IPO subscribed 10.98x on day 3, with retail at 11.71x and NII at 24.80x. The clinical nutrition company behind Pentasure and Pediagold lists 12 June; brokerages SBICAP and BP Equities recommend subscribe.